Daewon Pharmaceutical said it held working-level negotiations with Cigala Healthcare Group, a Saudi healthcare company, to conduct joint clinical trials for TG Fenon (Ingredient: fenofibrate), an oral Covid-19 treatment.TG Fenon is a hyperlipidemia drug that Daewon repurposed as a Covid-19 treatment
With the quick spread of the Omicron variant straining the nation’s emergency care system, the health authorities should brace for a spike in the number of mild Covid-19 patients, an expert said.Professor Oh Myoung-don of infectious disease at the Seoul National University Hospital, who leads the na
Korean pharmaceutical companies and drug distributors are collaborating with diagnostic kit manufacturers to supply testing kits quickly.The nation is witnessing a spike in demand for Covid-19 testing, especially after the government shifted quarantine policy to run PCR tests for high-risk groups on
Daewoong Pharmaceutical’s subsidiary iN Therapeutics said it raised 26 billion won ($21.6 million) bridge capital for new drug development.Last year, iN Therapeutics successfully attracted 14 billion won of Series A investment.The temporary funding came from new investors, Stic Ventures and Interves
Celltrion said Monday it has confirmed the safety of its inhaled Covid-19 antibody treatment through an Australian phase 1 clinical trial and plans to start global clinical trials for a cocktail version of the inhaled treatment.Inhalon Biopharma, Celltrion's global partner, proved the inhaled antibo
Biogen’s first anti-amyloid antibody, Alzheimer’s disease treatment Aduhelm (ingredient: aducanumab), is suffering a series of setbacks.According to the annual securities filing by Biogen on Thursday, the U.S. Federal Trade Commission (FTC) and the Securities and Exchange Commission (SEC) started se
Researchers at Seoul St.Mary’s Hospital have found that the risk of developing psoriasis increases when patients have metabolic syndrome.The team, led by Professor Lee Ji-yeon of the Department of Dermatology, concluded so after analyzing the National Health Insurance Service data on 5,644,324 adult
Quarantine officials talked about the possibility of returning to daily life on Friday, saying they will manage Covid-19 like the seasonal flu."Although the number of new virus cases keeps increasing, we have decided to gradually lift the quarantine regulations and try again to restore daily life --
Immunomic Therapeutics, a subsidiary of HLB, said it has received U.S. Food and Drug Administration’s approval to conduct the phase 1 clinical trial of ITI-3000, a Merkel cell carcinoma treatment.ITI-3000 is an anticancer vaccine made by combining LAMP1 (lysosomal-associated membrane protein) with t
Researchers at the Korea Advanced Institute of Science and Technology (KAIST) have developed a computational antibody design and used it to develop a neutralizing antibody that exhibits excellent effects against all Covid-19 variants, including Omicron.SARS-CoV-2 virus, which causes Covid-19 infecti
What aftereffects bother people most who were infected by Covid-19 but cured of the disease?A research paper published in the latest issue of the Korean Journal of Internal Medicine offered some clues to this question. The author is Kim Yun-jeong, a professor of infectious disease at the Catholic Un
Aptamer Sciences said on Friday that it signed a CDMO (contract development and manufacturing organization) agreement with China’s Asymchem for developing an anticancer drug.The deal involves GMP process development and production of clinical samples of AST-201, an aptamer-drug conjugate (ApDC)-base
A joint research team has confirmed the therapeutic effects and side effects of carotid artery radiation embolization in single-module liver cancer of five centimeters or larger is similar to liver resection surgery.Liver cancer is the seventh most common cancer in Korea. According to the National C
SK Bioscience said Turkey’s health authorities granted GMP certification to its vaccine plant, raising the chance of exporting self-developed vaccines.On Friday, the company said that the Turkish Medicines and Medical Devices Agency renewed GMP certification on the L House’s vaccine facility, manufa
MSD’s anti-PD-1 immunotherapy Keytruda (pembrolizumab) offered much more benefit than Takeda’s Adcetris (brentuximab vedotin) in progression-free survival and quality of life in relapsed/refractory classical Hodgkin lymphoma (cHL), a study showed.The latest issue of Blood Advances, published by the
Huons Global said it has completed restructuring its medical device business division by merging its subsidiary, Huons Medicare and Huons Medical, into Huons Meditech.Huons Meditech named Lee Sang-man as the company's first CEO. The company said that Lee would expand target markets at home and abroa
The government is likely to approve more Covid-19 self-test devices to meet the spiking demand for Covid-19 tests, sources said.Korea Biomedical Review learned on Friday that the Ministry of Food and Drug Safety (MFDS) would authorize some Covid-19 home test kits soon.“There are companies that appli
Amid the moves to ease quarantine controls in some European countries, a ranking quarantine official made it clear Thursday that Korea cannot adopt such a policy, saying, “Our situation is different from them.”“We are taking into account foreign countries’ quarantine policy. However, it is kind of h
The two leading presidential candidates and their camps exchanged verbal battles during the Lunar New Year holiday over foreign residents’ health insurance coverage.On Sunday, Yoon Suk-yeol, the standard-bearer of the conservative opposition People Power Party (PPP), said he would strengthen the reg
A research team presented a biomarker that could predict the treatment response of the lenalidomide maintenance therapy widely used in multiple myeloma (MM) for the first time.The team found that progression-free survival (PFS) and overall survival (OS) were meaningfully short in MM patients with hi